EPIGENE.COM Trademark

Trademark Overview


On Tuesday, December 21, 2010, a trademark application was filed for EPIGENE.COM with the United States Patent and Trademark Office. The USPTO has given the EPIGENE.COM trademark a serial number of 85202806. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2012. This trademark is owned by Epigenesis Pharmaceuticals, LLC. The EPIGENE.COM trademark is filed in the Pharmaceutical Products category with the following description:

medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, acute respiratory d...
epigene.com

General Information


Serial Number85202806
Word MarkEPIGENE.COM
Filing DateTuesday, December 21, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2011

Trademark Statements


Goods and Servicesmedical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ards), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (svt), adenosine stress tests, infantile respiratory distress syndrome (infantile rds), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (copd), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate
Pseudo MarkEPIGENESIS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 30, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpigenesis Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCranbury, NJ 08512

Party NameEpigenesis Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Friday, March 9, 2012UNDELIVERABLE MAIL - NO ACTION TAKEN
Monday, February 13, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 13, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 26, 2011UNDELIVERABLE MAIL - NO ACTION TAKEN
Friday, July 22, 2011UNDELIVERABLE MAIL - NO ACTION TAKEN
Tuesday, July 12, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 18, 2011NOTICE OF PUBLICATION
Tuesday, May 17, 2011PUBLISHED FOR OPPOSITION
Thursday, May 5, 2011WITHDRAWAL OF ATTORNEY GRANTED
Thursday, May 5, 2011TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Saturday, April 9, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 9, 2011ASSIGNED TO LIE
Tuesday, March 29, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 29, 2011EXAMINER'S AMENDMENT ENTERED
Tuesday, March 29, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 29, 2011EXAMINERS AMENDMENT E-MAILED
Tuesday, March 29, 2011EXAMINERS AMENDMENT -WRITTEN
Monday, March 21, 2011ASSIGNED TO EXAMINER
Friday, December 31, 2010NOTICE OF PSEUDO MARK MAILED
Thursday, December 30, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 24, 2010NEW APPLICATION ENTERED IN TRAM